Racial Inequities, Multiple Sclerosis, and Implementation of a Novel Treatment Algorithm at the Health System Level
Implementation of our novel health system intervention led to marked and equitable improvements in HET use and relapse rate reduction among Hispanic, Black, and White DMT-treated patients with MS. This indicates that implementing an algorithmic approach to increase HET use, particularly an affordable one, rituximab, can reduce racial and ethnic disparities in MS outcomes.
Authors
- Bonnie H. Li
- Michael H. Kanter (ORCID: https://orcid.org/0000-0002-1019-9311)
- Annette Langer‐Gould (ORCID: https://orcid.org/0000-0001-6891-7147)
- Stanley Xu (ORCID: https://orcid.org/0000-0002-4750-7672)
- Jessica Smith (ORCID: https://orcid.org/0000-0001-6585-323X)
- K. Choi
Institutions
- University of California, Los Angeles (US)
- Los Angeles Medical Center (US)
- Western Systems Research (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1212/wnl.0000000000213607
- Citations
- 4
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.89